CD274 and neoplasm: Finally, released metformin from the Met@BF nanohybrid at tumor sites significantly downregulated the PD-L1 level on tumor cells and subsequently enhanced T cell infiltration, thus curbing the development of primary and metastatic B16F10 tumor masses in mice (Figure 4).